Loading viewer...
investor_presentation
Format: PDF investor_presentation
Assertio presents Spring 2022 updates on its specialty pharmaceutical business, highlighting a major restructuring achieving $45 million in annual savings and a new management team. The company reports its first acquisition since 2015 (Otrexup from Antares) and marks the fourth consecutive quarter of positive cash flow, with 2022 net sales guidance of $126–$136 million.
investor_presentation
Comtech Telecommunications
investor_presentation
Roxgold
investor_presentation
J.Jill
Mrs. Bectors Food Specialities Q1 FY22 Investor Presentation
investor_presentationinvestor_presentation
32 Pages
Mrs. Bectors Food Specialities Limited